Type 2 Diabetes

New research from the Joslin Diabetes Center helps illuminate the process of glucose toxicity in pancreatic beta cells. Observing the behavior of these cells in lab rats following parial pancreatectomy, researchers were able to observe how small consistent rises in blood sugar levels typical of pre-diabetes caused changes in gene expression that impeded the ability of beta cells to produce insulin.

New findings comparing 3 decades of newly approved indications show the proportion of new approvals being supported by just 1 pivotal trial has quadrupled.

In the midst of the coronovirus epidemic, managing diabetes is now more important - and perhaps more challenging -than ever.   Even in the best of times, primary care physicians sometimes struggle to effectively treat patients with diabetes. However, patient fears, and restrictions in day-to-day life due to social distancing may make it more difficult for patients to get medications, arrive at appointments, or stay on track with physical activity and healthy eating.

For years the controversy regarding the connection between reproductive health and body mass index has raged on, leaving women and their doctors with more questions than answers.  Are overweight women less fertile? Does primary ovarian insufficiency increase risks for obesity and diabetes?

Sugar substitutes sure taste sweet, but let’s be honest, they’re never quite as satisfying as the real thing.  And until now, science has never been able to explain why.  But recently, researchers at Columbia University’s Zuckerman Institute have discovered neurons in the brains of mice that respond to sugar – not only on the tongue, but also in the gut.

Bhatt leads discussion on a new AHA statement regarding one of the most advancing fields of cardiovascular care.

A discussion about a recent scientific statement outlining the treatment of coronary artery disease in type 2 diabetics from the AHA with statement co-author Deepak Bhatt, MD.

Deepak Bhatt, MD, MPH, executive director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital talks with HCPLive's Patrick Campbell about the American Heart Association's recommendations from the lipid management portion oftheir scientific statement discussing both coronary artery disease (CAD) and type 2 diabetes (T2D).

Investigators compare cesarean delivery to vaginal delivery to understand the association between delivery type and obesity and type 2 diabetes.

Investigators from Saint Louis University discuss a new comparison of 2 drug classes that could reduce the risk of adverse cardiovascular events.

A new scientific statement from the AHA offers guidance to clinicians tasked with treating CAD in patients with type 2 diabetes.

A new study has identified a significant association between being born via cesarean delivery and increased risks of obesity and type 2 diabetes in adulthood.

Results of a new study dive deeper into the impact of preoperative metformin use in diabetics.

Discussing the impact of the ongoing outbreak on endocrinology practices and endocrinologists with the Executive Dean of the Faculty of Medicine and Health at University of Leeds.

A new perspective from federal and institutional experts explains the cause of disease severity and mortality in older, cardiovascular-risk patients.

New data from ENDO 2020 has uncovered a potential link between loss of meibomian glands and increased blood glucose levels.

Results of the 5-year Protocol T extension study are offering insight into the differences in real-world treatment and study protocol with anti-VEGF treatments.

A look at the state of cardiometabolic care based on research at ACC.20/WCC from a fourth-year medical student.

How new DAPA-HF findings continue to build the SGLT2 inhibitors' cardiovascular portfolio.

African American and Hispanic patients use devices for type 1 diabetes less than Caucasian patients.

Glucagon-like receptor agonists did not reduce the rate of hospitalization for heart failure as much as SGLT2 inhibitors did.

For every 1% higher baseline A1C, there was a 0.06 lower standardized CASI z-score.

A new subanalysis from the TWILIGHT trial found benefits of ticagrelor monotherapy remained consistent across both diabetics and nondiabetics.

Discussing the impact of rivaroxaban 2.5 mg BID plus aspirin in diabetics versus nondiabetics from the COMPASS trial with Deepak Bhatt, MD.

A board member of the college highlights 4 highly anticipated trials coming out of ACC 2020.

A study’s proposed findings of increased coronavirus risk shows how presenting half of a fact can influence our care during a pandemic.

Geeta Nayyar, MD, MBA, discusses how hydroxychloroquine and chloroquine affect patients with arthritis and how it differs for those with coronavirus.

An ACC board member explains the major cardiology college's decision to move the meeting online during the COVID-19 pandemic.

The Mount Sinai expert and ACC late-breaking presentation panelist highlights her most anticipated trial data and discussions in the upcoming meeting.

A new study of more than 30k Swedish men is shedding light on associations between early puberty and risk of T2D.